Catalyst Wire Dossier Catalyst Wire Dossier

Persantin IR

dipyridamole · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Persantin IR, covering 2014-10-24 to 2014-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects [Phase 1]

See pricing